How to Evaluate Hemp, CBD and Cannabis Companies: Filings, Metrics and Risks
This guide is for investors, buyers, lenders and founders who want to judge a hemp, CBD or cannabis company on its business rather than its press releases. You will learn how the three groups differ legally, where to find a company’s real numbers, which metrics tell you the most, and which risks are specific to this industry in late 2026. It names no stocks and makes no recommendations.
This article contains affiliate links. As an Amazon Associate, HempDollars earns from qualifying purchases, at no cost to you.
- “Hemp,” “CBD” and “cannabis” companies sit under different legal regimes. That difference drives their access to banking, loans and interstate markets.
- The federal hemp definition is changing. Some provisions of P.L. 119-37 took effect November 12, 2026, and most others are scheduled for December 11, 2026, unless Congress acts again.
- Audited SEC filings (10-K, 10-Q, 8-K) are the best primary source. Press releases and promoter newsletters are not.
- Watch revenue mix, gross margin, inventory, cash runway, dilution and going-concern language before you look at growth claims.
Table of Contents
Hemp, CBD and cannabis: three different legal positions
The old posts this guide replaces treated “CBD,” “marijuana” and “hemp” as one investment theme. They are not. A company’s legal category decides whether it can use ordinary banks, qualify for federal loans, ship across state lines and sell through mainstream retailers. Those things shape its cost of capital and its addressable market.
Hemp companies
The 2018 Farm Bill removed hemp from the Controlled Substances Act’s definition of marijuana. FinCEN’s 2020 guidance summarizes the definition that applied under that law: Cannabis sativa L. and its derivatives with a delta-9 THC concentration of not more than 0.3 percent on a dry-weight basis. Growers must hold a license under a USDA, state or tribal plan. Companies that grow fiber or grain, or that process hurd, bast fiber, seed oil or protein, are usually ordinary agricultural or manufacturing businesses with an extra layer of licensing and THC testing.
CBD companies
A CBD company may source legal hemp and still face a separate federal problem: the Food and Drug Administration. The SBA’s lending rules, citing FDA guidance, state that it is illegal under the Food, Drug, and Cosmetic Act to add CBD to any human or animal food, any dietary supplement and certain cosmetics, because CBD is the active ingredient in an approved drug. So a company selling CBD gummies, drinks or capsules carries regulatory risk that a fiber processor does not, even if both buy from licensed farms. For more on that, see our guide to hemp foods and FDA rules.
Marijuana (cannabis) companies
Marijuana remains illegal under federal law, even where states license it. The SEC’s 2018 investor alert on marijuana investments warned that some marijuana-related companies may be at risk of criminal prosecution because of the business they are in. FinCEN’s 2020 hemp guidance states that it does not replace the agency’s separate 2014 guidance for marijuana-related businesses, and the SBA treats plant-touching marijuana businesses as ineligible for its loans. Some public “cannabis” companies run both hemp and marijuana operations. When that happens, the riskier activity tends to set the terms for the whole company.
| Factor | Hemp (fiber, grain, seed) | Hemp-derived CBD products | State-legal marijuana |
|---|---|---|---|
| Federal status | Legal if it meets the federal hemp definition | Hemp is legal; FDA limits on food and supplement use | Controlled substance |
| Bank due diligence | Standard customer due diligence (FinCEN 2020) | Standard, plus product compliance questions | 2014 marijuana guidance applies |
| SBA 7(a)/504 loans | Eligible with documentation | Case by case under SBA factors | Ineligible |
| Main regulatory risk | THC testing, licensing, definition changes | FDA, state product rules, new per-container THC cap | Federal enforcement, state licensing |
The 2026 federal definition change and why it matters to valuation
As of November 18, 2026, the Congressional Research Service (Legal Sidebar LSB11496, October 28, 2026) describes the status this way. The November 2025 appropriations law, P.L. 119-37, rewrote the federal hemp definition. It moved to a total-THC basis, set a 0.4 mg total-THC-per-container cap for final products, and excluded cannabinoids that the plant cannot naturally produce. A later continuing resolution, P.L. 119-103, delayed most of those changes to December 11, 2026. It left the exclusion for cannabinoids “not capable of being naturally produced” on its original November 12, 2026 date. CRS lists pending bills that would delay the changes by two more years or repeal them. None of those is law as of this writing.
For anyone evaluating a company, the practical question is how much revenue comes from products that will fall outside the new definition. A company that makes most of its money from intoxicating hemp-derived THC products could lose much of its legal market on the effective date. A fiber or grain processor is far less exposed. Read the risk factors and revenue disclosures for direct answers, and treat silence on this topic as a red flag. Our explainer on the new federal hemp definition covers the details.
Where to find reliable information
- SEC EDGAR. Companies that report to the SEC file annual reports (10-K), quarterly reports (10-Q) and current reports (8-K) there. The SEC’s “How to Read a 10-K” bulletin notes that the company writes the 10-K, its CEO and CFO must certify it, and the SEC does not vouch for its accuracy.
- Offering documents. Private companies raising money under Regulation D must file a short Form D notice after the first sale, according to Investor.gov. Crowdfunding issuers file through registered intermediaries.
- Licensing records. State departments of agriculture and USDA AMS can confirm whether a grower or processor holds a valid hemp license.
- Market data. For context on crop economics, the USDA NASS National Hemp Report is the main federal survey. NASS reported that U.S. hemp production was worth $739 million in 2025, and that floral hemp grown in the open made up $574 million of it. Grain was $8.09 million and fiber $13.5 million. A company’s growth story should fit those market sizes.
The SEC’s microcap fraud guidance cautions that information about small, thinly traded companies is often scarce, which makes false stories easier to spread. If a company does not file with the SEC, you may have to rely on whatever it chooses to tell you.
How to read a hemp company’s 10-K
SEC rules require a 10-K to follow a set order. These are the sections that matter most for this industry:
- Item 1, Business. What does the company actually do: grow, process, formulate, wholesale or retail? Does it own its processing, or does it buy from third parties? In the SEC’s 2021 case against CanaFarma Hemp Products, the agency alleged that the company told investors it was a “fully integrated” operation processing hemp from its own farm, when its products used hemp from third parties.
- Item 1A, Risk Factors. Look for specific discussion of the 2026 hemp definition, FDA policy, state product bans, banking and payment processing, and crop or testing failures. Generic boilerplate is less useful than numbers.
- Item 3, Legal Proceedings. Regulatory actions, product liability suits and supplier disputes.
- Item 7, MD&A. Management’s own account of results, liquidity and capital resources. Compare its tone with the financial statements.
- Item 8, Financial Statements. Read the auditor’s report first. A going-concern paragraph means the auditor has substantial doubt that the company can keep operating for the next year without new money. Then read the notes on inventory, impairments, related parties, debt and subsequent events.
- Item 9A, Controls and Procedures. Material weaknesses in internal controls deserve attention in a small company.
8-K filings between annual reports flag auditor changes, executive departures, new financing and material agreements. Frequent auditor changes or late filings are worth noting.
Key metrics to check
| Metric | What it tells you | Hemp-specific angle |
|---|---|---|
| Revenue by product line | Where the money really comes from | Share from products affected by the new THC rules |
| Gross margin | Pricing power after direct costs | Crop price swings and biomass gluts compress margins |
| Inventory and write-downs | Whether stock is selling or aging | Hemp biomass, extracts and finished goods can lose value or become non-compliant |
| Operating cash flow and runway | Months of cash at current burn | Seasonal crop cycles can hide or exaggerate burn |
| Share count over time | Dilution of existing holders | Common in small companies that fund losses with stock |
| Customer and supplier concentration | Dependence on a few counterparties | Offtake contracts and single processors are common |
| Related-party transactions | Money moving to insiders | Farms, leases or processing owned by executives |
Illustrative example: imagine a company reporting rising revenue while its inventory grows faster than sales and its share count doubles in a year. Those three numbers together suggest it is building product it cannot sell and paying for it by issuing stock. The headline revenue growth hides the problem.
A book on reading financial statements
Look for a recent edition that walks through balance sheets, cash flow statements and footnotes with worked examples.
Check price on AmazonAs an Amazon Associate, HempDollars earns from qualifying purchases.
Industry-specific risks
- Definition and compliance risk. Total-THC testing and the per-container cap can turn compliant inventory into non-compliant inventory. USDA AMS is also delaying enforcement of the DEA-registered lab testing requirement only until December 31, 2026. See our guide to THC testing and compliance.
- Commodity risk. Hemp prices vary widely by crop type and year. A company whose costs depend on one crop type is exposed to that market.
- Banking and payments. FinCEN guidance lets banks serve hemp businesses with standard due diligence. Banks may still ask for licenses and test reports, and payment processors have their own policies.
- Promotion risk. The SEC has warned that fraudsters exploit “hot” industries, and has suspended trading in some marijuana-related stocks. Our guide to hemp investment red flags lists the warning signs.
If you are looking at a private company to buy rather than a stock, the same framework applies, with deeper document review. See our due diligence checklist.
Frequently asked questions
Is a CBD company the same as a hemp company?
Not legally. CBD may come from licensed hemp, but adding it to food or dietary supplements raises FDA issues that a fiber or grain business does not face. Many lenders and banks treat these as separate risk categories.
Does the new federal hemp definition affect fiber and grain companies?
Less directly. The per-container THC cap applies to final hemp-derived cannabinoid products. Growers of any crop type still need compliant THC levels, and total-THC testing can affect them. Check how each company describes its own exposure.
Where can I find a hemp company’s audited financials?
If it reports to the SEC, use EDGAR to find its 10-K and 10-Q filings. Private companies are not required to publish financials, so ask for audited or reviewed statements before investing or lending.
What does a going-concern warning mean?
The auditor has substantial doubt about the company’s ability to continue operating over the next year without new funding or other changes. It is not a prediction of failure, but it signals likely dilution or new debt.
Can HempDollars tell me which hemp stocks to buy?
No. This site provides education only. For decisions about your own money, speak with a licensed financial professional and check their registration on FINRA BrokerCheck.
This article is for education only and is not investment, legal, or tax advice. Rules change; confirm with your state department of agriculture and USDA AMS before acting.
Sources
- Congressional Research Service, Delay in Changes to Hemp Definition: Cannabinoids Not Capable of Being Naturally Produced by the Cannabis Plant, LSB11496 (2026)
- FinCEN, FIN-2020-G001: Due Diligence Requirements under the Bank Secrecy Act for Hemp-Related Business Customers (2020)
- U.S. Small Business Administration, SOP 50 10 8.1: Lender and Development Company Loan Programs, effective October 1, 2026 (2026)
- SEC Office of Investor Education and Advocacy, Investor Alert: Marijuana-Related Investments (2014)
- SEC Office of Investor Education and Advocacy, Investor Alert: Marijuana Investments and Fraud (2018)
- SEC, Investor Bulletin: How to Read a 10-K
- Investor.gov, Microcap Fraud
- Investor.gov, Form D
- SEC, Litigation Release No. 25240: SEC v. CanaFarma Hemp Products Corp., et al. (2021)
- USDA National Agricultural Statistics Service, National Hemp Report (April 16, 2026)
- USDA Agricultural Marketing Service, Hemp Production (2026)
Figures last checked: November 18, 2026.
Originally posted 2019-11-21 23:00:56. Republished by Blog Post Promoter
🌱 Finished reading? You earned 5 seeds.
Every article you read to the end earns seeds in Hemp Empire, our free hemp farming tycoon game. Play now →
Some links may be affiliate links. As an Amazon Associate, HempDollars earns from qualifying purchases.

